NASDAQ: BDRX
Biodexa Pharmaceuticals PLC Stock Ownership - Who owns Biodexa Pharmaceuticals?

Insider buying vs selling

Have Biodexa Pharmaceuticals PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BDRX insiders and whales buy or sell their stock.

BDRX Shareholders

What type of owners hold Biodexa Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Simon Turton0.00%2,765$1.82kInsider
Armist0.00%15$9.90Institution
Armistice Capital LLC0.00%15$9.90Institution
Gamma Investing LLC0.00%1$0.66Institution
Gammai0.00%1$0.66Institution
Rhumbline Advisers0.00%0$0.00Institution
Allie10.00%0$0.00Institution
Allied Private Wealth LLC0.00%0$0.00Institution
Caitong International Asset Management Co Ltd0.00%0$0.00Institution
Hilton Head Capital Partners LLC0.00%0$0.00Institution

1 of 2

BDRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SCNI0.00%4.50%
AKTX0.00%2.86%Net BuyingNet Buying
NCNA0.00%0.01%
BDRX0.00%0.00%
CDT0.00%100.00%Net SellingNet Selling

Biodexa Pharmaceuticals Stock Ownership FAQ

Who owns Biodexa Pharmaceuticals?

Biodexa Pharmaceuticals (NASDAQ: BDRX) is owned by 0.00% institutional shareholders, 0.00% Biodexa Pharmaceuticals insiders, and 100.00% retail investors. Simon Turton is the largest individual Biodexa Pharmaceuticals shareholder, owning 2765.00 shares representing 0.00% of the company. Simon Turton's Biodexa Pharmaceuticals shares are currently valued at $3.59k.

If you're new to stock investing, here's how to buy Biodexa Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.